Suppr超能文献

生前移植优化干预措施:同意的法律地位

Pre-mortem transplantation optimizing interventions: the legal status of consent.

作者信息

Downie Jocelyn, Rajotte Chantelle, Shea Alison

机构信息

Faculty of Law and Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.

出版信息

Can J Anaesth. 2008 Jul;55(7):458-69. doi: 10.1007/BF03016313.

Abstract

PURPOSE

The focus of this paper is on consent issues surrounding pre-mortem transplantation optimizing interventions. First, we explore the potential consequences of the different types of pre-mortem transplantation optimizing interventions that might be used, and we examine the current Canadian practice with respect to these interventions. We then analyze the status of consent to pre-mortem transplantation optimizing interventions under the current legal framework. Finally, we provide recommendations on how to improve the current legal framework.

PRINCIPAL FINDINGS

In Canada, as in many countries in the world today, there is a shortage of organs available for transplantation. Canada's deceased donor rate was 12.8 per million in 2005, a rate that has been stable over the past 12 years. At the end of 2005, the number of Canadians on waiting lists for an organ was 4,025 (125 out of every million Canadians). In total, 283 patients died in 2005 while waiting for new organs. To address the shortage of available organs, a number of changes have recently been made to organ donation practices and protocols. The use of pre-mortem transplantation optimizing interventions is a significant issue in organ donation, and it has become increasingly important to reflect on the use of such interventions, in light of these new practices. "Pre-mortem transplantation optimizing interventions" are interventions that are carried out on a patient, before his or her death, for the purpose of optimizing the chances of successful transplantation.

CONCLUSIONS

We argue that consent is legally required and must be express and competent patients have the legal authority to consent; but the law with respect to legal authority to consent on behalf of incompetent patients varies across the country. We come to the unsettling conclusion that the legality of pre-mortem transplantation optimizing interventions in many circumstances is at best questionable. We provide concrete recommendations (draft statutory text) on how to improve the current legal framework.

摘要

目的

本文重点关注围绕临终前移植优化干预措施的同意问题。首先,我们探讨可能采用的不同类型临终前移植优化干预措施的潜在后果,并审视加拿大目前在这些干预措施方面的做法。然后,我们分析现行法律框架下临终前移植优化干预措施的同意状况。最后,我们就如何改进现行法律框架提出建议。

主要发现

在加拿大,如同当今世界许多国家一样,可用于移植的器官短缺。2005年加拿大的已故捐赠者率为每百万人口12.8人,这一比率在过去12年中一直稳定。2005年底,等待器官移植的加拿大人有4025名(每百万加拿大人中有125名)。2005年共有283名患者在等待新器官时死亡。为解决可用器官短缺问题,最近对器官捐赠做法和方案进行了一些改变。临终前移植优化干预措施的使用是器官捐赠中的一个重要问题,鉴于这些新做法,反思此类干预措施的使用变得越发重要。“临终前移植优化干预措施”是指在患者死亡前对其实施的、旨在优化移植成功几率的干预措施。

结论

我们认为同意在法律上是必需的,且必须是明示的,有行为能力的患者有同意的法律权限;但代表无行为能力患者同意的法律权限在全国各不相同。我们得出了一个令人不安的结论,即在许多情况下,临终前移植优化干预措施的合法性充其量是有疑问的。我们就如何改进现行法律框架提供了具体建议(法定文本草案)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验